يعرض 1 - 20 نتائج من 99 نتيجة بحث عن '"F Griesinger"', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, [Griesinger F] Department of Hematology and Oncology, Pius-Hospital, University of Oldenburg, Oldenburg, Germany. [Curigliano G] European Institute of Oncology, IRCCS, Milan, Italy. Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. [Thomas M] Department of Thoracic Oncology, Thoraxklinik, University Heidelberg and Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany. [Subbiah V] Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, USA. [Baik CS] Division of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, USA. [Tan DSW] Division of Medical Oncology, National Cancer Centre Singapore, Singapore. [Garralda E] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia
    Annals of Oncology, 33(11), 1168-1178. Oxford University Press

    وصف الملف: application/pdf

  2. 2
    Academic Journal

    المساهمون: S. Novello, J. Mazières, I.-J. Oh, J. de Castro, M. R. Migliorino, Å. Helland, R. Dziadziuszko, F. Griesinger, A. Kotb, A. Zeaiter, A. Cardona, B. Balas, H. K. Johannsdottir, A. Das-Gupta, J. Wolf

    Relation: info:eu-repo/semantics/altIdentifier/pmid/29668860; info:eu-repo/semantics/altIdentifier/wos/WOS:000438508100016; volume:29; issue:06; firstpage:1409; lastpage:1416; numberofpages:8; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/2318/1664051; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85050333912

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
    Academic Journal
  16. 16
  17. 17

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Pulmonary medicine, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology, University of Zurich, Stahel, R A

    المصدر: Annals of oncology : official journal of the European Society for Medical Oncology
    r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
    instname
    ETOP/IFCT 4-12 STIMULI Collaborators 2022, ' Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial ', Annals of Oncology, vol. 33, no. 1, pp. 67-79 . https://doi.org/10.1016/j.annonc.2021.09.011
    Annals of Oncology, 33(1), 67-79. Oxford University Press

    وصف الملف: Print-Electronic

  18. 18
  19. 19
  20. 20